One News
Breaking · 2 sources

Just broke · 2 sources · 49m ago

Medical Experts Warn Against Using Cancer Medication in 'Heightmaxxing' Trend

Doctors are cautioning that a viral social media trend involving the misuse of the cancer drug Erdafitinib for height growth poses severe health risks to teenagers.

Coverage spectrum

Read at your length

Doctors are cautioning that a viral social media trend involving the misuse of the cancer drug Erdafitinib for height growth poses severe health risks to teenagers.

Doctors warn that teens taking erdafitinib, a cancer drug, to grow taller in a trend called heightmaxxing face severe health risks. Erdafitinib, a cancer medication, is being misused by teens chasing height growth. Medical experts detail the severe risks of the heightmaxxing trend.

New York Post reported the story as "Viral ‘heightmaxxing’ trend has teen boys taking cancer drugs to grow taller despite doctors' warnings."

2 sources have covered this story, including New York Post and Fox News. The earliest reporting in the cluster landed 48 minutes ago.

How each side is reporting it

Left0 outlets

How the left is reporting it

No coverage from this side yet.

Center0 outlets

How the wires + center are reporting it

No coverage from this side yet.

Where sources agree

No shared facts cached yet.

Where they diverge

No contradictions cached yet.

How it spread

Fox News reported it first, Nov 10, 4:14 PM ET. 2 outlets carried it over 1h 53m, all on the right.All in the United States.

Left 0Center 0Right 2No left or center outlets yet.

Time since the first report

  1. FirstFox NewsNov 10, 4:14 PM ETRight
  2. +1h 53mNew York PostNov 10, 6:06 PM ETRight

Claim ledger

  1. [01]
    Verified

    Core event reported by 2 independent outlets across the spectrum.

    2 corroborating · 1 primary-source link

  2. [02]
    Disputed

    Key facts present in mainstream desks; corroboration thin from wires.

    2 corroborating

Where they stand

Framings — how each side is covering it

All sources covering this story